UPDATE : Monday, December 17, 2018
상단여백
‘I will help make Korea original holder of anticancer drugs’
“Original technologies are important for national development. We will deve...
by So Jae-hyeon  |  2018-10-29 14:43
라인
‘Bio Solution’s value to rise on arthritis cell therapy’
Bio Solution will be able to drive up its market capitalization once it obt...
by Nam Doo-hyun  |  2018-10-25 16:30
라인
Samsung BioLogics posts ₩101.1 billion in Q3 sales
Samsung BioLogics said Wednesday that it recorded 101.1 billion won ($88.7 ...
by Lee Han-soo  |  2018-10-25 11:02
라인
CancerRop advances into Malaysian gene market
CancerRop said Wednesday that it has signed a cooperative agreement with Ca...
by Lee Han-soo  |  2018-10-24 17:49
라인
Celltrion releases clinical trial results for Remsima SC in EU and US
Celltrion has presented phase 1 and 3 clinical trials for Remsima SC, the s...
by Lee Han-soo  |  2018-10-24 16:47
라인
Will synthetic biology be vital in smart therapeutics?
Synthetic biology, which designs biological components and systems in new w...
by Nam Doo-hyun  |  2018-10-24 16:40
라인
Biotech shares tank amid nosediving of Seoul stocks
Biotech and pharmaceutical shares plunged on Tuesday, hurt mainly by the ov...
by Nam Doo-hyun  |  2018-10-24 11:35
라인
‘Antibody drug developer AbClon noteworthy’
AbClon, a developer of innovative antibody medicines, is likely to achieve ...
by Nam Doo-hyun  |  2018-10-22 14:49
라인
L&C BIO sets offering price at ₩24,000 for KOSDAQ debut
L&C BIO, a tissue engineering company, said on Friday that it has set its o...
by So Jae-hyeon  |  2018-10-22 14:12
라인
'Superbug' fears bring antibiotics developers under spotlight
Investors are paying keen attention to antibiotics developers amid growing ...
by Nam Doo-hyun  |  2018-10-22 11:53
라인
Celltrion, Samsung BioLogics named Fortune’s ‘Future 50’
Fortune, a U.S.-based multinational business magazine, has named Samsung Bi...
by Lee Han-soo  |  2018-10-19 16:34
라인
CancerRop launches unit to develop cell therapies
CancerRop established CancerRop Cell on Wednesday, a subsidiary to develop ...
by Lee Han-soo  |  2018-10-18 15:25
라인
Biogen, Samsung Bioepis announce European launch of Imraldi
Biogen and Samsung Bioepis said Tuesday they will launch Imraldi, the compa...
by Lee Han-soo  |  2018-10-17 17:28
라인
Bio stocks listed under ‘tech exception policy’ perform better
Biotech and medical companies that went public under the Korea Exchange’s “...
by Nam Doo-hyun  |  2018-10-15 12:27
라인
Merck to supply Samsung’s biosimilar to US Veterans Affairs Dept.
Merck, known as MSD outside the United States and Canada, announced that is...
by Lee Han-soo  |  2018-10-11 16:31
라인
US drug advisory recommends Celltrion’s Rituxan biosimilar for approval
Celltrion said Thursday that the U.S. Oncologic Drug Advisory Committee (OD...
by Lee Han-soo  |  2018-10-11 12:10
라인
‘Korea publishes many biotech papers but rarely links them to biz’
South Korea’s ranking in biotech competitiveness, announced by the U.S. sci...
by Nam Doo-hyun  |  2018-10-10 16:35
라인
GC opens new cell research center
GC said Monday that it has dedicated a new integrated research center in a ...
by Lee Han-soo  |  2018-10-10 11:45
라인
More biotech stocks come in top 20 on KOSDAQ
The number of pharmaceutical and biotech firms within the top 20 companies ...
by Nam Doo-hyun  |  2018-10-10 11:20
라인
Newly listed biotech firms perform poorly on KOSDAQ
Biotech companies that went public in the first half of this year have show...
by Nam Doo-hyun  |  2018-10-04 13:09
여백
여백
여백
Back to Top